As part of the group’s capital restructuring after Eurazeo (through its Nov Santé Actions Non Cotées fund) and Crédit Mutuel Equity acquired a stake in Proteor, a well-known player in the orthopedics market, Mayer Brown provided advice to the management team of the company. Bpifrance and BNP Paribas Développement are also reinvesting in the transaction, and Ardian, a minority shareholder since 2021, is leaving.